Evaluation of the Feasibility and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma-Reference-Cited by-同舟云学术

Evaluation of the Feasibility and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Published:2013 Issue:1 Volume:52 Page:63-70
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Muta Tsuyoshi¹,Miyamoto Toshihiro¹,Fujisaki Tomoaki²,Ohno Yuju³,Kamimura Tomohiko⁴,Kato Koji¹,Takenaka Katsuto¹,Iwasaki Hiromi¹,Eto Tetsuya⁵,Takamatsu Yasushi⁶,Teshima Takanori⁷,Akashi Koichi¹

Affiliation:

1. Department of Hematology/Oncology, Kyushu University Hospital, Japan

2. Department of Internal Medicine, Matsuyama Red-Cross Hospital, Japan

3. Department of Hematology, Kitakyushu Municipal Medical Center, Japan

4. Department of Hematology, Hara-Sanshin Hospital, Japan

5. Department of Hematology, Hamanomachi Hospital, Japan

6. Division of Medical Oncology, Hematology, and Infectious Disease, Fukuoka University Hospital, Japan

7. Department of Hematology and Oncology, Hokkaido University Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/52/1/52_52.8390/_pdf

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older;Cancer;2021-08-10

2. Outpatient hematopoietic cell transplantation for older adults with hematologic malignancies: Results at an academic tertiary-care center;Journal of Geriatric Oncology;2021-08

3. Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma;Bone Marrow Transplantation;2020-08-11

4. Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis;Current Research in Translational Medicine;2020-08

5. Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2020-06